Kantify
@kantify.com
Solve the missing link in drug discovery. Kantify's post-docking AI engine delivers a 25% experimental hit rate for undruggable targets. Access a 10B+ compound library to turn stalled targets into validated leads at high velocity.
Kantify's Company Logos
Kantify's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#7ECAC6
Half Baked
126, 202, 198
177, 42, 64
38, 0, 2, 21
#DB9963
Di Serria
219, 153, 99
27, 62, 62
0, 30, 55, 14
#3C4447
Cape Cod
60, 68, 71
196, 8, 26
15, 4, 0, 72
About Kantify
Kantify is a computational drug discovery company that is dedicated to improving human health through the power of Artificial Intelligence (AI). With a focus on oncology, neuromuscular disorders, and rare diseases, Kantify utilizes AI to discover therapeutic targets, small molecules, and targeted protein degraders. Their team consists of highly talented individuals who possess deep expertise in applied AI and computational biology.
Headquartered in Belgium, a country renowned for its pharmaceutical industry, Kantify is driven by a mission to push the frontiers of science and improve human health. By leveraging AI technology, Kantify is able to make millions of calculations before conducting lab testing, thereby reducing the environmental footprint of drug discovery. Their values of excellence, diversity, curiosity, and kindness guide their work.
Led by CEO Segolene Martin and CTO Nik Subramanian, Kantify is dedicated to revolutionizing drug discovery and discovering tomorrow's breakthrough therapies using Artificial Intelligence
Company type
Privately Held
Year founded
2016
Company size
2-10 employees
